| P/E (FY) | 48.3 | Sales (TTM) | $1.29B |
| Earnings (TTM) | $67.7M | ROE | 12.48% |
| Net Margin | 4.54% | ROIC | 15.76% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | 29.40% | Sales Growth 3Y | 17.87% |
Progyny is a benefits management company providing fertility, family building, and women's health benefits solutions in the United States. Its fertility benefits include a smart cycle treatment bundle, concierge-style member support, and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution, plus care management for pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and reimbursement programs for adoption, surrogacy, doula, and travel.
| Market Cap | $2.46B | Trading Days | 1692 |
| 52W High | 33.06 |
| 52W Low | 16.10 |
| % Off High | −5.13% |
| YTD | 22.16% | 1Y | 37.41% |
| 3Y | −24.88% | 5Y | −43.49% |
| Since incept. (ann.) | 10.53% |
Reportable 100%
| Ann. Volatility (1Y) | 55.72% | Ann. Volatility (3Y) | 52.40% |
| Sharpe (1Y) | 0.82 | Sharpe (3Y) | 0.11 |
| Max Drawdown (1Y) | −42.65% | Max Drawdown (3Y) | −68.14% |
| Beta (3Y, vs SPY) | 0.87 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| SHC | Sotera Health Co | $5.00B | 64.9 |
| VMD | VIEMED HEALTHCARE, INC. | $446.6M | 31.5 |
| DVA | DAVITA INC. | $15.47B | 24.5 |
| AGL | agilon health, inc. | $41.04B | — |
| PARK | Park Dental Partners, Inc. | $79.7M | — |
| MRAI | Marpai, Inc. | $53.1M | — |
| CCEL | CRYO CELL INTERNATIONAL INC | $27.2M | — |
| MGRX | MANGOCEUTICALS, INC. | $9.5M | — |
| BRTX | BioRestorative Therapies, Inc. | $6.3M | — |
| FMS | Fresenius Medical Care AG | — | — |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.46B | — |
| NRIX | Nurix Therapeutics, Inc. | $2.45B | — |